Filing Details
- Accession Number:
- 0001209191-13-029242
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-28 19:53:00
- Reporting Period:
- 2013-05-24
- Filing Date:
- 2013-05-28
- Accepted Time:
- 2013-05-28 19:53:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356857 | Trius Therapeutics Inc | TSRX | Pharmaceutical Preparations (2834) | 201320630 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1479790 | Philippe Prokocimer | C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Dr, # 105 San Diego CA 92121 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-05-24 | 12,000 | $7.93 | 86,022 | No | 4 | S | Indirect | By The Philippe Prokocimer and Maria Prokocimer Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By The Philippe Prokocimer and Maria Prokocimer Family Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,429 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- The weighted average sales price for the transaction reported was $7.926667, and the range of prices were between $7.92 and $7.96. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided
Billionaire Hedge Funds
